    <SEC-DOCUMENT>0001104659-23-047802-index.html : 20230420
    <SEC-HEADER>0001104659-23-047802.hdr.sgml : 20230420
    <ACCEPTANCE-DATETIME>20230420163240
    ACCESSION NUMBER:		0001104659-23-047802
    CONFORMED SUBMISSION TYPE:	424B3
    PUBLIC DOCUMENT COUNT:		4
    FILED AS OF DATE:		20230420
    DATE AS OF CHANGE:		20230420

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Adaptimmune Therapeutics PLC
    		CENTRAL INDEX KEY:			0001621227
    		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
    		IRS NUMBER:				000000000
    		STATE OF INCORPORATION:			X0
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		424B3
    		SEC ACT:		1933 Act
    		SEC FILE NUMBER:	333-271145
    		FILM NUMBER:		23833553

    	BUSINESS ADDRESS:
    		STREET 1:		60 JUBILEE AVENUE
    		STREET 2:		MILTON PARK
    		CITY:			ABINGDON, OXFORDSHIRE
    		STATE:			X0
    		ZIP:			OX14 4RX
    		BUSINESS PHONE:		44 1235 430000

    	MAIL ADDRESS:
    		STREET 1:		60 JUBILEE AVENUE
    		STREET 2:		MILTON PARK
    		CITY:			ABINGDON, OXFORDSHIRE
    		STATE:			X0
    		ZIP:			OX14 4RX

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Adaptimmune Ltd
    		DATE OF NAME CHANGE:	20141001
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>424B3
    <SEQUENCE>1
    <FILENAME>tm239007-7_424b3.htm
    <DESCRIPTION>424B3
    <TEXT>
    Document 1 - file: tm239007-7_424b3.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>2
    <FILENAME>lg_adaptimmune-4c.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 2 - file: lg_adaptimmune-4c.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>3
    <FILENAME>lg_tcr-4c.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 3 - file: lg_tcr-4c.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>4
    <FILENAME>lg_pipersandler-4c.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 4 - file: lg_pipersandler-4c.jpg

    </DOCUMENT>
    </SEC-DOCUMENT>